China Overseas Nuoxin International Holdings Limited (0464.HK)
HKD 0.35
(-4.11%)
HKD 0.35
(-4.11%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 109.1 Million HKD | 133.17% |
| 2022 | 46.79 Million HKD | -57.69% |
| 2021 | 110.57 Million HKD | -46.19% |
| 2020 | 205.48 Million HKD | -11.41% |
| 2019 | 231.95 Million HKD | -8.15% |
| 2018 | 252.53 Million HKD | 57.32% |
| 2017 | 160.52 Million HKD | -3.01% |
| 2016 | 165.5 Million HKD | 11.09% |
| 2015 | 148.98 Million HKD | -5.87% |
| 2014 | 158.27 Million HKD | -11.93% |
| 2013 | 179.72 Million HKD | -13.61% |
| 2012 | 208.03 Million HKD | -2.75% |
| 2011 | 213.92 Million HKD | -6.68% |
| 2010 | 229.24 Million HKD | 5.18% |
| 2009 | 217.95 Million HKD | 7.32% |
| 2008 | 203.08 Million HKD | -11.42% |
| 2007 | 229.27 Million HKD | 8.54% |
| 2006 | 211.22 Million HKD | 25.84% |
| 2005 | 167.85 Million HKD | -19.29% |
| 2004 | 207.97 Million HKD | 43.87% |
| 2003 | 144.55 Million HKD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 FY | 109.1 Million HKD | 133.17% |
| 2023 Q2 | 52.25 Million HKD | 0.0% |
| 2023 Q4 | 109.1 Million HKD | 0.0% |
| 2022 Q4 | 46.79 Million HKD | 0.0% |
| 2022 FY | 46.79 Million HKD | -57.69% |
| 2022 Q2 | 73.43 Million HKD | 0.0% |
| 2021 Q4 | 110.57 Million HKD | 0.0% |
| 2021 FY | 110.57 Million HKD | -46.19% |
| 2021 Q2 | 211.92 Million HKD | 0.0% |
| 2020 Q4 | 205.48 Million HKD | 0.0% |
| 2020 FY | 205.48 Million HKD | -11.41% |
| 2020 Q2 | 249.86 Million HKD | 0.0% |
| 2019 Q2 | 271.96 Million HKD | 0.0% |
| 2019 FY | 231.95 Million HKD | -8.15% |
| 2019 Q4 | 231.95 Million HKD | 0.0% |
| 2018 FY | 252.53 Million HKD | 57.32% |
| 2018 Q4 | 252.53 Million HKD | 0.0% |
| 2018 Q2 | 214.12 Million HKD | 0.0% |
| 2017 Q4 | 160.52 Million HKD | 0.0% |
| 2017 FY | 160.52 Million HKD | -3.01% |
| 2017 Q2 | 166.68 Million HKD | 0.0% |
| 2016 Q2 | 177.45 Million HKD | 0.0% |
| 2016 Q4 | 165.5 Million HKD | 0.0% |
| 2016 FY | 165.5 Million HKD | 11.09% |
| 2015 FY | 148.98 Million HKD | -5.87% |
| 2015 Q4 | 148.98 Million HKD | 0.0% |
| 2015 Q2 | 171.64 Million HKD | 0.0% |
| 2014 Q4 | 158.27 Million HKD | 0.0% |
| 2014 FY | 158.27 Million HKD | -11.93% |
| 2014 Q2 | 179.64 Million HKD | 0.0% |
| 2013 Q2 | 221.06 Million HKD | 0.0% |
| 2013 Q4 | 179.72 Million HKD | 0.0% |
| 2013 FY | 179.72 Million HKD | -13.61% |
| 2012 Q2 | 218.73 Million HKD | 6.47% |
| 2012 Q1 | 205.43 Million HKD | -3.97% |
| 2012 Q4 | 208.03 Million HKD | 6.99% |
| 2012 FY | 208.03 Million HKD | -2.75% |
| 2012 Q3 | 194.44 Million HKD | -11.11% |
| 2011 Q4 | 213.92 Million HKD | 0.0% |
| 2011 Q2 | 272.73 Million HKD | 0.0% |
| 2011 FY | 213.92 Million HKD | -6.68% |
| 2010 Q2 | 255.86 Million HKD | 0.0% |
| 2010 FY | 229.24 Million HKD | 5.18% |
| 2010 Q4 | 229.24 Million HKD | 0.0% |
| 2009 FY | 217.95 Million HKD | 7.32% |
| 2009 Q4 | 217.95 Million HKD | 0.0% |
| 2008 FY | 203.08 Million HKD | -11.42% |
| 2007 FY | 229.27 Million HKD | 8.54% |
| 2006 FY | 211.22 Million HKD | 25.84% |
| 2005 FY | 167.85 Million HKD | -19.29% |
| 2004 FY | 207.97 Million HKD | 43.87% |
| 2003 FY | 144.55 Million HKD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 308.05 Million HKD | 64.584% |
| Innovative Pharmaceutical Biotech Limited | 1.06 Billion HKD | 89.742% |
| Prosperous Future Holdings Limited | 177.1 Million HKD | 38.399% |
| Huasheng International Holding Limited | 675.58 Million HKD | 83.851% |
| Fourace Industries Group Holdings Limited | 61.8 Million HKD | -76.525% |
| Evergreen Products Group Limited | 786.46 Million HKD | 86.128% |
| EC Healthcare | 2.97 Billion HKD | 96.327% |
| Ming Fai International Holdings Limited | 772.01 Million HKD | 85.868% |
| Blue Moon Group Holdings Limited | 1.61 Billion HKD | 93.256% |
| SuperRobotics Holdings Limited | 172.27 Million HKD | 36.669% |
| Takbo Group Holdings Limited | 42.84 Million HKD | -154.617% |
| Hyfusin Group Holdings Limited | 181.34 Million HKD | 39.839% |